NCT01092559View on ClinicalTrials.gov

Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Nitric Oxide generated by the GeNO nitrosyl delivery system

single short-term exposure to inhaled nitric oxide using the GeNO nitrosyl delivery system.

Trial Locations (3)

44106

University Hospital, Cleveland

75390

University of Texas Southwestern Medical Center, Dallas

02111

Tufts, Boston

Sponsors

Lead Sponsor

Geno LLC
All Listed Sponsors
lead

Geno LLC

INDUSTRY

NCT01092559 - Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide | Biotech Hunter | Biotech Hunter